Highlights
NASDAQ: RIGL       Rigel Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
2.52   -0.13 (4.91%)  2.47 - 2.74  1,166,800

Overview

 
Avg Volume (4 weeks):2,328,094
4 Weeks Range:1.98 - 3.10
4 Weeks Price Volatility (%):
48.21%
52 Weeks Range:1.56 - 3.10
52 Weeks Price Volatility (%):
62.34%
Average Price Target: 10.00
Price Target Upside/Downside: +7.48

Headlines



No recent Headlines for this stock.


Business Background

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken over all responsibility to develop and market the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes Fostamatinib - ITP, Fostamatinib - AIHA, Fostamatinib - IgAN, BGB324 - Oral AXL Inhibitor, ATI-50001 & 50002 - JAK Inhibitors, DS-3032-MDM2 Inhibitor, THF-beta Inhibitors and AZD0449- Inhaled JAK Inhibitor.

  Be the first to like this.
 


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers